Jason Russell Chambers, Director at ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ (HRT), bought 6,800 shares at $4.59 ($32K) on 2008-09-15, disclosed to the SEC on 2008-09-16.
Open-market purchase of $32k HRT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.59 | 100 | $459 | 1.4% |
| 2 | $4.60 | 400 | $2K | 5.7% |
| 3 | $4.75 | 2,000 | $10K | 29.5% |
| 4 | $4.75 | 4,300 | $20K | 63.4% |
| Total | $4.74 avg | 6,800 | $32K | 100% |
| Filing → |
| HRT | SELL | 2015-06-16 | $8K | — | Filing → |
| HRT | SELL | 2014-08-14 | $37K | — | Filing → |
| HRT | BUY | 2008-09-15 | $4K | — | Filing → |